Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Anfossi

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
The American Journal of Pathology|July 27, 2016
Hodgkin Lymphoma Cells Have a Specific Long Noncoding RNA Expression PatternSimone Anfossi, George A Calin
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2020
Gut microbiota: a new player in regulating immune- and chemo-therapy efficacySimone Anfossi, George A Calin
The Journal of Experimental Medicine|February 6, 2020
When non-coding is not enoughSimone Anfossi, George A Calin
Nature Reviews. Clinical Oncology|May 23, 2018
Clinical utility of circulating non-coding RNAs - an updateSimone Anfossi, Anna Babayan, Klaus Pantel, et al.
Advances in Experimental Medicine and Biology|May 14, 2018
MicroRNAs, Regulatory Messengers Inside and Outside Cancer CellsSimone Anfossi, Xiao Fu, Rahul Nagvekar, et al.
International Journal of Molecular Sciences|May 15, 2020
The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell MalignanciesSherien M El-Daly, Recep Bayraktar, Simone Anfossi, et al.
Journal of Clinical Medicine|November 4, 2020
A Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor MicroenvironmentMihnea P Dragomir, Vlad Moisoiu, Roxana Manaila, et al.
Genes, Chromosomes & Cancer|December 23, 2018
Role of miRNAs in immune responses and immunotherapy in cancerMaria Angelica Cortez, Simone Anfossi, Rishab Ramapriyan, et al.
ACS Synthetic Biology|December 15, 2018
S-MiRAGE: A Quantitative, Secreted RNA-Based Reporter of Gene Expression and Cell PersistenceKinshuk Mitra, William N Feist, Simone Anfossi, et al.
Breast Cancer Research : BCR|January 25, 2026
High levels of circulating miR-19a-3p in patients with metastatic HER2 + breast cancer are associated with a favorable prognosis and anti-tumor immune responsesEvan N Cohen, Hui Gao, Sanda Tin, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|July 27, 2016
Hodgkin Lymphoma Cells Have a Specific Long Noncoding RNA Expression PatternSimone Anfossi, George A Calin
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2020
Gut microbiota: a new player in regulating immune- and chemo-therapy efficacySimone Anfossi, George A Calin
The Journal of Experimental Medicine|February 6, 2020
When non-coding is not enoughSimone Anfossi, George A Calin
Nature Reviews. Clinical Oncology|May 23, 2018
Clinical utility of circulating non-coding RNAs - an updateSimone Anfossi, Anna Babayan, Klaus Pantel, et al.
Advances in Experimental Medicine and Biology|May 14, 2018
MicroRNAs, Regulatory Messengers Inside and Outside Cancer CellsSimone Anfossi, Xiao Fu, Rahul Nagvekar, et al.
International Journal of Molecular Sciences|May 15, 2020
The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell MalignanciesSherien M El-Daly, Recep Bayraktar, Simone Anfossi, et al.
Journal of Clinical Medicine|November 4, 2020
A Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor MicroenvironmentMihnea P Dragomir, Vlad Moisoiu, Roxana Manaila, et al.
Genes, Chromosomes & Cancer|December 23, 2018
Role of miRNAs in immune responses and immunotherapy in cancerMaria Angelica Cortez, Simone Anfossi, Rishab Ramapriyan, et al.
ACS Synthetic Biology|December 15, 2018
S-MiRAGE: A Quantitative, Secreted RNA-Based Reporter of Gene Expression and Cell PersistenceKinshuk Mitra, William N Feist, Simone Anfossi, et al.
Breast Cancer Research : BCR|January 25, 2026
High levels of circulating miR-19a-3p in patients with metastatic HER2 + breast cancer are associated with a favorable prognosis and anti-tumor immune responsesEvan N Cohen, Hui Gao, Sanda Tin, et al.
Pageof 4